People

Services

Industries

Firm

About

Knowledge

Careers

News

Events

Contact

Connect

Privacy Policy

Disclaimer

Terms of Use

Accessibility

Payments

Legal

Calgary

Toronto

Edmonton

Ottawa

Vancouver

New York

Montréal

Brynne Harding

Litigation Lawyer at Bennett Jones Calgary

Partner

Tyler McDonough

Commercial Litigation Lawyer at Bennett Jones Calgary

In Alberta, punitive cost awards in administrative proceedings may be a thing of the past. In <a rel="noopener noreferrer" rel="noopener noreferrer" href="https://www.canlii.org/en/ab/abca/doc/2022/2022abca336/2022abca336.html" target="_blank">Jinnah v Alberta Dental Association and College</a>, Alberta’s top court established a new presumption that the profession as a whole—and not individual members—should bear the costs of all but the most serious disciplinary proceedings.

Court of Appeal tells Regulators to Pony Up for Disciplinary Proceedings

Munaf Mohamed KC

Commercial Litigation & Economic Crimes Lawyer | Trials & Appeals

A bold Alberta Court of King's Bench decision, <a rel="noopener noreferrer" rel="noopener noreferrer" href="https://www.canlii.org/en/ab/abkb/doc/2023/2023abkb209/2023abkb209.html?" target="_blank">Alberta Health Services v Johnston, </a><a rel="noopener noreferrer" rel="noopener noreferrer" href="https://www.canlii.org/en/ab/abkb/doc/2023/2023abkb209/2023abkb209.html?" target="_blank">2023 ABKB 209</a>, declined to follow Ontario appellate authority on the issue and established the tort of harassment in Alberta to fill a "gap in the law".

Alberta Gains New Tort of Harassment and Limits Defamation By Government Actors

Alberta Gains New Tort of Harassment and Limits Defamation By Government Actors—Online and IRL

David J. Wahl, FCIArb

Construction Arbitration & Litigation Lawyer at Bennett Jones Calgary

In its latest SR&ED decision, <a href="https://www.canlii.org/en/ca/fca/doc/2022/2022fca72/2022fca72.html?autocompleteStr=2022%20fca%2072&autocompletePos=1">National R&D Inc v Canada, 2022 FCA 72</a>, the Federal Court of Appeal reminded litigants of the first principles of expert evidence, the rules and requirements govern it, and of the dangers of failing to do so.

National R and D A Cautionary Tale about Expert Evidence

National R&D: A Cautionary Tale about Expert Evidence

Since the advent of the COVID-19 pandemic, state responses to the virus have become the subject of vigorous public debate. While some impugn measures they say are too weak to protect the vulnerable, others lament incursions on their liberties.

Do Medical Professionals Have Freedom of Expression

Do Medical Professionals Have Freedom of Expression?

Serge Dupont

Senior Advisor at Bennett Jones Ottawa

Senior Advisor

Policy and business leaders in 2026 are confronting disruptive global forces that pose daunting economic and financial risks while also transforming markets and creating avenues for growth over the next years.

Economic Outlook Mid Year 2026

A Changing World: New Risks, New Opportunities

2026 Mid-Year Economic Outlook

Alison G. FitzGerald

International Arbitration Lawyer at Bennett Jones Ottawa

Nasra Moumin

Commercial Litigation Lawyer at Bennett Jones Toronto

Associate

Global trade policy is rapidly reshaping the regulatory and commercial landscape for life sciences companies. This update explores how evolving US tariff measures, national security reviews, CUSMA renewal uncertainty and expanding export controls are affecting pharmaceutical and medical device manufacturers operating across borders. The authors also examine Canada&rsquo;s response and the growing compliance, supply chain and market access challenges facing the sector in 2026 and beyond.

The Impact of Global Trade on the Life Sciences Sector

Vincent M. de Grandpré

IP Lawyer | Life Sciences & Tech

Melissa M. Dimilta

Intellectual Property Lawyer at Bennett Jones Toronto

Partner, Trademark Agent

As part of a deeply interconnected global sector, the life sciences industry in Canada is undergoing significant change alongside broad macroeconomic and geopolitical shifts.&nbsp;The Bennett Jones Life Sciences team looks at the top issues and developments affecting the industry in 2026.

2026 Life Sciences outlook

Legal and Market Trends to Watch This Year

Life Sciences Outlook 2026

Emily P. Kettel

Cross-border collaborations are central to the life sciences industry, but they can also raise complex questions about patent infringement liability in Canada. This update examines the Federal Court&rsquo;s recent decision in Adeia Guides Inc v Videotron Ltd and its implications for companies involved in the development, supply and commercialization of patented products and services. The authors explore how Canadian law approaches common design infringement, experimental use exemptions and the potential liability of foreign partners whose activities contribute to products ultimately sold in Canada.

Life Sciences Collaborations and the Risk of Joint Patent Infringement

Aaron E. Sonshine

Corporate Finance, Mergers and Acquisitions and Corporate Governance Lawyer at Bennett Jones Toronto

Partner 

The life sciences sector is experiencing a renewed wave of M&amp;A activity driven by patent expiries, expanding investor appetite and growing demand for innovative therapies and technologies. Drawing on insights shared at the Bloom Burton &amp; Co. Healthcare Investor Conference, this update explores the key trends shaping dealmaking in Canada and globally, including increased competition for assets, rising private transactions and growing investment in emerging markets such as China. The author also examines why current market conditions point to continued momentum across the sector in the second half of 2026.

Counsel Comment: Jonsson v. Lymer, 2020 ABCA 167

From the Same Authors